Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 2

Status

Recruiting 43Completed 33Unknown 25Not yet recruiting 16Active not recruiting 11Terminated 5Withdrawn 1

Sponsor Class

INDUSTRY 18OTHER 5

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Genitourinary 5

Conditions

Breast Neoplasms 720Neoplasms 458Prostatic Neoplasms 397Carcinoma, Non-Small-Cell Lung 387Lung Neoplasms 308Leukemia, Myeloid, Acute 300Multiple Myeloma 269Colorectal Neoplasms 242Neoplasm Metastasis 240Pancreatic Neoplasms 236Leukemia 235Melanoma 214Lymphoma 213Precursor Cell Lymphoblastic Leukemia-Lymphoma 204Brain Neoplasms 193Recurrence 178Head and Neck Neoplasms 177Lymphoma, Non-Hodgkin 173Leukemia, Lymphocytic, Chronic, B-Cell 168Myelodysplastic Syndromes 166Ovarian Neoplasms 160Carcinoma, Hepatocellular 154Glioblastoma 149Carcinoma, Renal Cell 137Rectal Neoplasms 134Colonic Neoplasms 129Lymphoma, Large B-Cell, Diffuse 125Lymphoma, Follicular 125Hodgkin Disease 115Squamous Cell Carcinoma of Head and Neck 109

Interventions

pembrolizumab 1enzalutamide 1avelumab 1Sugars 1Pentosan Sulfuric Polyester 1Capsules 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Terminated × OTHER × Non-Muscle Invasive Bladder Neoplasms × Clear all
NCT04412070 2025-11-21

ALU

Hopital Foch

Terminated
20 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT03549650 2022-03-04

Prevention and Management of Intravesical BCG-related Lower Urinary Tract Symptoms

Sir Mortimer B. Davis - Jewish General Hospital

Phase 2 Terminated
3 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Lower Urinary Tract Symptoms

NCT03498196 2020-08-24

A Window of Opportunity Trial: Avelumab in Non-metastatic Muscle Invasive Bladder Cancer

Baylor College of Medicine

Phase 1/2 Terminated
1 enrolled 10 charts
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT03167151 2020-07-31

PemBla

University of Oxford

Phase 1/2 Terminated
6 enrolled 12 charts
Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT02605863 2018-10-03

Enzalutamide for Bladder Cancer Chemoprevention

University of Rochester

Phase 2 Terminated
1 enrolled 6 charts
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡